CORT Short Volume
Corcept Therapeutics Incorporated (CORT) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $12.73B, listed on NASDAQ, employing roughly 730 people, carrying a beta of 0.45 to the broader market. Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Led by Joseph K. Belanoff, public since 2004-04-14.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-10-14
- Short Volume
- 159.5K
- Total Volume
- 265.7K
- Short %
- 60.05%
- 30-Day Avg Short %
- 56.17%
Showing 30 days of FINRA short volume data for Corcept Therapeutics Incorporated.
Learn how short volume is reported and how to read the data →
Frequently asked CORT short volume questions
- What is the daily CORT short volume?
- As of Oct 14, 2026, Corcept Therapeutics Incorporated (CORT) short volume is 159.5K shares against 265.7K total reported volume, or 60.05% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is CORT short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does CORT short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.